Literature DB >> 16003647

Epidemiology of diastolic heart failure.

Theophilius E Owan1, Margaret M Redfield.   

Abstract

Heart failure (HF) is a major public health problem. Clinical studies suggest that a significant proportion of patients with HF have preserved ejection fraction, a clinical syndrome commonly referred to as diastolic HF (DHF). One of the purposes of epidemiological studies is to identify unmet public health needs in a population and to quantify the magnitude of the problem in a manner that is free from the referral bias inherent in clinical studies. We review current epidemiological data estimating the prevalence of DHF, highlight the challenges posed by existing data, and suggest focus for future studies on the epidemiology of DHF. We limited the review to studies that met our definition of population-based studies (eg, studies drawing participants from a defined community or all consecutive referrals to a health facility that is the sole provider to a defined community). Studies relevant to the epidemiology of each stage of DHF (American College of Cardiology/American Heart Association stages A-D) were reviewed. These epidemiological studies clearly define the magnitude of this health care problem and underscore the urgent need for studies elucidating the natural history, pathophysiology, and optimal diagnostic and management strategy for this extremely common clinical syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16003647     DOI: 10.1016/j.pcad.2005.02.010

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  116 in total

1.  Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.

Authors:  Guangxi Li; Sonal Rachmale; Marija Kojicic; Khurram Shahjehan; Michael Malinchoc; Daryl J Kor; Ognjen Gajic
Journal:  Transfusion       Date:  2010-08-17       Impact factor: 3.157

2.  The natural history of preclinical diastolic dysfunction: a population-based study.

Authors:  Mark W Vogel; Joshua P Slusser; David O Hodge; Horng H Chen
Journal:  Circ Heart Fail       Date:  2012-01-25       Impact factor: 8.790

3.  Hypertension and reduced renal function in an 83-year-old patient.

Authors:  Andrea Ungar; Lorella Lambertucci; Chiara Agresti; Riccardo Pini; Maria Boddi; Maria Consuelo Valentini; Gianfranco Parati; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control Analysis.

Authors:  Carolyn L Lekavich; Debra J Barksdale; Jia-Rong Wu; Virginia Neelon; Jamie Crandell; Eric J Velazquez
Journal:  J Card Fail       Date:  2017-07-14       Impact factor: 5.712

5.  Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.

Authors:  Yong Seon Choi; Ana Barbosa Marcondes de Mattos; Dan Shao; Tao Li; Miranda Nabben; Maengjo Kim; Wang Wang; Rong Tian; Stephen C Kolwicz
Journal:  J Mol Cell Cardiol       Date:  2016-09-28       Impact factor: 5.000

Review 6.  Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.

Authors:  Erik H Howell; Scott J Cameron
Journal:  Cardiol J       Date:  2016-09-26       Impact factor: 2.737

Review 7.  Diagnosis of diastolic heart failure.

Authors:  Hidekatsu Fukuta; William C Little
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

8.  Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction.

Authors:  Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

Review 9.  [Diastolic heart failure].

Authors:  R Wachter
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

10.  Lusitropic effects of dobutamine in young and aged mice in vivo.

Authors:  Emily D Hirleman; Qianli Yu; Douglas F Larson
Journal:  J Extra Corpor Technol       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.